文献速递头颈外科

美国老年头颈癌生存者合并症患病率研究

Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-09-25

本研究基于SEER-Medicare数据库,回顾性分析2004至2011年首次诊断头颈鳞状细胞癌的10524例患者(平均年龄74.8岁),评估诊断时及生存期合并症患病率,并比较不同治疗方式下合并症发生的差异。结果显示高血压、高脂血症、慢阻肺和糖尿病最常见且随时间增加,治疗相关合并症如肺炎、吞咽困难、体重减轻等在治疗后短期和长期显著上升,单纯手术者风险较低。

要点

  • 老年头颈鳞癌患者诊断时高血压、高脂血症、慢阻肺和糖尿病常见。
  • 治疗后肺炎、吞咽困难、体重减轻等合并症风险显著增加。
  • 单纯手术较放疗/化疗者治疗相关合并症风险更低。

核心结论

  • 头颈鳞癌治疗后合并症负担大,需在随访中关注。

研究设计与样本

  • 回顾性横断面研究,基于SEER-Medicare数据库纳入2004至2011年首次诊断头颈鳞癌的10524例患者,平均年龄74.8岁。

主要发现

  • 诊断时最常见合并症为高血压、高脂血症、慢阻肺和糖尿病,且随时间增加。
  • 治疗后肺炎、吞咽困难、体重减轻、营养不良和牙齿问题的概率在短期和长期显著上升(P < .05)。
  • 诊断后5年内最可能出现新发高血压、吞咽困难、贫血和体重减轻。
  • 单纯手术与涉及放疗和/或化疗的治疗相比,这些治疗相关合并症诊断风险更低(P < .05)。

临床怎么用

  • 对头颈癌生存者应加强合并症监测,尤其是治疗相关合并症。
  • 治疗选择时考虑合并症风险,单纯手术可能降低相关风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate the prevalence of comorbidities among patients with head and neck squamous cell carcinoma (HNSCC) at the time of their cancer diagnosis and during their survivorship trajectory. The second aim was to evaluate the differences in comorbidities developed according to treatment type received. STUDY DESIGN: Retrospective cross-sectional. SETTING: SEER (Surveillance, Epidemiology, and End Results)-Medicare linked database. SUBJECTS AND METHODS: Individuals with a first-incident primary diagnosis of HNSCC from 2004 to 2011 per the SEER-Medicare database were included in analysis. The presence or absence of 30 comorbid conditions of interest was identified during distinct periods and analyzed according to treatment with surgery alone, primary (chemo)radiation, or surgery with (chemo)radiation. RESULTS: The study population consisted of 10,524 individuals diagnosed with HNSCC, with a mean age of 74.8 years. At diagnosis, hypertension, hyperlipidemia, chronic obstructive pulmonary disease, and diabetes were the most prevalent comorbidities, and they increased over time. The probability of developing treatment-related comorbidities such as pneumonia, dysphagia, weight loss, malnutrition, and dental issues rose significantly in the short and long term following treatment ( P < .05). By 5 years from cancer diagnosis, patients were most likely to have newly diagnosed hypertension, dysphagia, anemia, and weight loss. Primary surgery alone was associated with a lower risk of diagnosis with these treatment-related comorbidities, as compared with treatments involving radiation therapy and/or chemotherapy in the primary or adjuvant settings ( P < .05). CONCLUSIONS: There is a large burden of comorbidities among patients following HNSCC treatment, which warrant clinical attention during surveillance.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Eytan DF, Blackford AL, Eisele DW, et al. Prevalence of Comorbidities among Older Head and Neck Cancer Survivors in the United States. Otolaryngol Head Neck Surg. 2018. PMID: 30252608. doi:10.1177/0194599818796163

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。